Muhammad Adrish, MD, MBA (@adrishmd) 's Twitter Profile
Muhammad Adrish, MD, MBA

@adrishmd

Faculty @BCMDeptMedicine | Alum @IsenbergUMass @EinsteinMed @AllamaIqbalMed | Assoc Editor @BMJOpen_Resp | Interest: Airways #MedEd| #ProudPakiAmericanšŸ‡µšŸ‡°šŸ‡ŗšŸ‡ø

ID: 1445309864

linkhttps://www.linkedin.com/in/muhammad-adrish-md-mba-fccp-fccm-387903b6 calendar_today21-05-2013 02:45:39

1,1K Tweet

594 Followers

371 Following

Muhammad Adrish, MD, MBA (@adrishmd) 's Twitter Profile Photo

Grateful for the educational mission of #CHESTSEEK, which has been invaluable in shaping my role as an educator at my institution. Proud to be part of a community that prioritizes education! #CHEST2024 CHEST CHEST Airways Disorders Network

Grateful for the educational mission of #CHESTSEEK, which has been invaluable in shaping my role as an educator at my institution. Proud to be part of a community that prioritizes education! #CHEST2024
<a href="/accpchest/">CHEST</a> <a href="/CHESTAirways/">CHEST Airways Disorders Network</a>
Muhammad Adrish, MD, MBA (@adrishmd) 's Twitter Profile Photo

Enjoying the Airway Sessions at #CHEST2024? Come Join Us in Rm 204AB at 11:15 AM Learn about the ways you can be a part of those preparations for the conference sessions and numerous other opportunities for which you don’t need to be a steering committee member

Enjoying the Airway Sessions at #CHEST2024?

Come Join Us in Rm 204AB at 11:15 AM 

Learn about the ways you can be a part of those preparations for the conference sessions and numerous other opportunities for which you don’t need to be a steering committee member
Muhammad Adrish, MD, MBA (@adrishmd) 's Twitter Profile Photo

Big thanks to Conrad and Lisa for the surprise gift! So grateful for the thoughtful gesture. Excited to continue working with you both at the Council of Networks for next couple of years šŸŽšŸ˜Š #Teamwork #Grateful CHEST CHEST Airways Disorders Network

Big thanks to Conrad and Lisa for the surprise gift! So grateful for the thoughtful gesture. Excited to continue working with you both at the Council of Networks for next couple of years šŸŽšŸ˜Š 

#Teamwork #Grateful <a href="/accpchest/">CHEST</a> <a href="/CHESTAirways/">CHEST Airways Disorders Network</a>
ERS publications (@erspublications) 's Twitter Profile Photo

ERJ Open Research: Short-term recombinant human DNase treatment was able to reduce airway extracellular DNA levels in obstructive airway disease and may represent a novel treatment option for non-T2 related inflammationĀ bit.ly/4fW3HAQ

ERJ Open Research: Short-term recombinant human DNase treatment was able to reduce airway extracellular DNA levels in obstructive airway disease and may represent a novel treatment option for non-T2 related inflammationĀ bit.ly/4fW3HAQ
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours (EXPECTS trial) nej.md/3QTnMxG #Neurology

Original Article: Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours (EXPECTS trial) nej.md/3QTnMxG 

#Neurology
Muhammad Adrish, MD, MBA (@adrishmd) 's Twitter Profile Photo

Join our dynamic Section of Pulmonary, Critical Care & Sleep Medicine at Baylor College of Medicine! It’s a great opportunity to work and grow in a collaborative, academic team. Apply here: jobs.bcm.edu/job/Pulmonolog… #Pulmonary #CriticalCare #SleepMedicine #MedTwitter #FacultyJobs

NEJM (@nejm) 's Twitter Profile Photo

Original Article: First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate (PREDMETH trial) nej.md/4kdaf0o Editorial: Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis? nej.md/4mhaHfW #ATS2025 | American Thoracic Society (ATS)

Original Article: First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate (PREDMETH trial) nej.md/4kdaf0o 

Editorial: Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis? nej.md/4mhaHfW 

#ATS2025 | <a href="/atscommunity/">American Thoracic Society (ATS)</a>
ATS AII (@ats_aii) 's Twitter Profile Photo

Based on the results of the MATINEE, METREX, AND METREO studies, mepolizumab is now FDA approved for patients with COPD and eosinophilia! An exciting new development in the world of COPD. #COPD #eosinophils

NEJM (@nejm) 's Twitter Profile Photo

Presented at #CCR25: In a cluster-randomized, crossover trial, hospital-wide use of lactated Ringer’s solution as compared with normal saline did not alter the incidence of death or hospital readmission within 90 days. Full trial results: nej.md/45SaEBs

Presented at #CCR25:

In a cluster-randomized, crossover trial, hospital-wide use of lactated Ringer’s solution as compared with normal saline did not alter the incidence of death or hospital readmission within 90 days. Full trial results: nej.md/45SaEBs
CHESTĀ® Journal (@journal_chest) 's Twitter Profile Photo

INSIDE LOOK šŸ‘€ Read from the upcoming issue (July 8): Original research indicates that clinical remission is a realistic goal, sustainable up to two years in around one-third of patients w/ severe eosinophilic #asthma receiving benralizumab. hubs.la/Q03vrqbf0 #JournalCHEST

INSIDE LOOK šŸ‘€ Read from the upcoming issue (July 8): Original research indicates that clinical remission is a realistic goal, sustainable up to two years in around one-third of patients w/ severe eosinophilic #asthma receiving benralizumab. hubs.la/Q03vrqbf0
#JournalCHEST
Muhammad Adrish, MD, MBA (@adrishmd) 's Twitter Profile Photo

Advances in Asthma Diagnosis and ManagementĀ is now open for submissions until 5th January 2026. The link for the Call for Papers can be found here:Ā  bmjopenrespres.bmj.com/pages/topic-co… BMJ Open Respiratory

ThoraxBMJ (@thoraxbmj) 's Twitter Profile Photo

Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial. thorax.bmj.com/content/80/9/6… @mathioudakisag

Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial. thorax.bmj.com/content/80/9/6…  @mathioudakisag